Glaukos Corp. (GKOS)
117.10
-3.90
(-3.22%)
USD |
NYSE |
Feb 19, 16:00
117.42
+0.32
(+0.27%)
Pre-Market: 07:54
Glaukos Research and Development Expense (Quarterly) : 43.65M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 569.00M |
| Intuitive Surgical, Inc. | 352.90M |
| ResMed, Inc. | 90.97M |
| Globus Medical, Inc. | 38.07M |
| Plus Therapeutics, Inc. | 2.436M |